Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections

医学 噬菌体 重症监护医学 软组织 皮肤病科 病理 生物 生物化学 基因 大肠杆菌
作者
Willem‐Jan Metsemakers,Jolien Onsea,T. Fintan Moriarty,Nikoloz Pruidze,Lia Nadareishvili,Mariam Dadiani,Mzia Kutateladze
出处
期刊:Clinical Microbiology and Infection [Elsevier BV]
卷期号:29 (6): 695-701 被引量:38
标识
DOI:10.1016/j.cmi.2023.01.011
摘要

Bacteriophage therapy has a long history in the treatment of musculoskeletal and skin/soft tissue infections, particularly in the former Soviet Union. Due to the global rise in antimicrobial resistance, phage application has experienced a resurgence of interest and expanded to many countries.This narrative review aims to provide clinical microbiologists, infectious disease specialists and surgeons a brief history of bacteriophage therapy for human musculoskeletal and soft tissue infections, as well as data on current practices and ongoing clinical studies.A search of PubMed and Clinicaltrials.gov was performed to identify relevant studies. Search terms were 'bacteriophage therapy', 'musculoskeletal infection' and 'soft tissue infection'. The bibliography of all retrieved articles was checked for additional relevant references.Past and current data on the use of bacteriophage therapy for human musculoskeletal, skin and soft tissue infections are evaluated. Moreover, we present the clinical trials registered in public databases. Based on current clinical experience and data, several scenarios of bacteriophage application for human therapy are examined. Finally, we discuss legislative hurdles in the regulatory approval process and present future perspectives for bacteriophage therapy.Antimicrobial resistance is one of the most important global public health challenges. Several different alternatives to conventional antibiotics are under development; bacteriophage therapy is one of them. Currently, therapeutic use of phages is restrained by regulatory hurdles and largely limited to sporadic authorization in compassionate use or under temporary approval as new drugs in Europe and the US. Although bacteriophage therapy seems to be safe and clinical results of phage treatment are promising, future data from high-quality (randomized controlled) trials could provide a better understanding of the reasonable minimal criteria required for expansion of bacteriophage therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
嘻嘻哈哈的应助被思川采纳,获得10
1秒前
水煮电吹风的应助被思川采纳,获得10
1秒前
2秒前
2秒前
Hello的应助被牧百川采纳,获得10
2秒前
徐明完成签到 ,获得积分10
3秒前
111发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
4秒前
5秒前
5秒前
科研通AI6.4的应助被tlc_191026采纳,获得10
6秒前
6秒前
xx发布了新的文献求助10
6秒前
renn发布了新的文献求助20
8秒前
CodeCraft的应助被单薄的尔烟采纳,获得10
8秒前
9秒前
郑睿涛发布了新的文献求助10
9秒前
云峰发布了新的文献求助10
9秒前
duoduozs完成签到,获得积分10
10秒前
amxwindy完成签到,获得积分20
10秒前
11秒前
JamesPei的应助被1097采纳,获得10
11秒前
木兮不嘻嘻完成签到 ,获得积分10
11秒前
11秒前
11秒前
12秒前
Elle发布了新的文献求助10
12秒前
香蕉寒珊发布了新的文献求助10
12秒前
orixero的应助被牧百川采纳,获得10
13秒前
挚友发布了新的文献求助10
14秒前
15秒前
16秒前
16秒前
111舒舒发布了新的文献求助10
17秒前
唱歌的被子完成签到 ,获得积分10
18秒前
Lucas的应助被Zhaihuiru采纳,获得10
18秒前
renn发布了新的文献求助20
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183449
求助须知:如何正确求助?哪些是违规求助? 9572834
关于积分的说明 21827509
捐赠科研通 7780646
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480371